FTC releases interim staff report on prescription drug middlemen
Federal Trade Commission
- Named role
- Report subject
- HHI coverage
- 0 paired / 1
Exact official-record label
Prime Therapeutics LLC
Pharmacy benefit manager named as a recipient of an FTC Section 6(b) order discussed in the interim staff report.
Exact source label, not a standalone legal-entity, ownership, liability, or market-power determination.
Official labelPrime Therapeutics LLC
Policy organizationPrime Therapeutics LLCOfficial label / 1 record / 2024
- Record identityExact source labelNot legal-entity resolution
- Official coverage1 dated record2024
- Market scope1 contextLinked by the official record
- Permitted useRecord tracingNot a liability finding
Official record chronology
Why this exact label appears
Jul 9, 2024
MonitoringFederal Trade Commission
FTC releases interim staff report on prescription drug middlemen
The FTC published interim findings on PBM concentration and vertical integration, including aggregate shares for the largest PBMs.
Named as Report subject
The FTC interim report identifies Prime Therapeutics among the six PBMs that received Section 6(b) orders.
Descriptive economic context
Public HHI evidence around each record
Each row searches the linked market profile for strict pre-event, same-year, and strict post-event observations. Missing anchors remain visible.
0Paired
0One-sided
1Unavailable
- Strict pre
- Unavailable
- No earlier HHI
- Event year
- Unavailable
- No same-year HHI
- Strict post
- Unavailable
- No later HHI
- Pre-post change
- Not available
- Pair not available
Before/after HHI differences are descriptive comparisons between discrete public releases. They do not estimate the causal effect of the policy event.
Bounded market context
Markets linked by the cited records
United States / Health care
PBMs
1 named record / 0 paired HHI windows
Report subject
A market link records the scope named by the official event. It does not establish that every named organization participates throughout that market or define a relevant antitrust market for a different matter.
Source custody
Official records behind the dossier
Federal Trade Commission / agency report
Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies
Accessed May 16, 2026. Federal Trade Commission, FTC Releases Interim Staff Report on Prescription Drug Middlemen, July 9 2024.
Reproducible record packet
Reuse the exact organization dossier
Filtered index and relationship routes preserve the organization slug, exact role, event ID, market context, source URL, and inference guardrails.
- Organization ID
- pent-prime-therapeutics
- Profile slug
- prime-therapeutics-llc
- Named edges
- 1
- License
- CC BY 4.0
Official-record interpretation boundary
These dossiers compile exact organization labels from official public records. They do not resolve corporate identity, ownership, control, affiliate status, liability, or market power beyond what the cited record expressly states.
A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.